Does MITOXANTRONE Cause Product use in unapproved indication? 177 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Product use in unapproved indication have been filed in association with MITOXANTRONE (mitoXANTRONE). This represents 4.3% of all adverse event reports for MITOXANTRONE.
177
Reports of Product use in unapproved indication with MITOXANTRONE
4.3%
of all MITOXANTRONE reports
53
Deaths
58
Hospitalizations
How Dangerous Is Product use in unapproved indication From MITOXANTRONE?
Of the 177 reports, 53 (29.9%) resulted in death, 58 (32.8%) required hospitalization, and 19 (10.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOXANTRONE. However, 177 reports have been filed with the FAERS database.
What Other Side Effects Does MITOXANTRONE Cause?
Febrile neutropenia (668)
Off label use (368)
Neutropenia (296)
Drug ineffective (293)
Thrombocytopenia (256)
Sepsis (240)
Pyrexia (214)
Disease progression (173)
Acute myeloid leukaemia (167)
Pneumonia (157)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which MITOXANTRONE Alternatives Have Lower Product use in unapproved indication Risk?
MITOXANTRONE vs MITRAGYNINE\HERBALS
MITOXANTRONE vs MIZORIBINE
MITOXANTRONE vs MOBOCERTINIB
MITOXANTRONE vs MOCLOBEMIDE
MITOXANTRONE vs MODAFINIL